TELETRADER News
7/16, 6:14 PM (Source: TeleTrader)
more TeleTrader news

Pfizer, BioNTech: FDA full approval review hopefully by January

Pfizer Inc. and BioNTech SE stated on Friday they are hoping the United States Food and Drug Administration (FDA) will review their application for the full approval of their vaccine against COVID-19 by January.

The companies added they intend to ask for approval for the regular use of their vaccine in children between the ages of 12 and 15 after they collect sufficient data on its effects. The FDA allowed the emergency use of the jab in kids from that age group back in May.

The same month, Pfizer and BioNTech submitted a request with the FDA for the full approval of their vaccine.

Breaking the News / JR